829 related articles for article (PubMed ID: 24895310)
1. Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guérin ΔureC::hly Δpdx1 in mice.
Gengenbacher M; Vogelzang A; Schuerer S; Lazar D; Kaiser P; Kaufmann SH
mBio; 2014 Jun; 5(3):e01262-14. PubMed ID: 24895310
[TBL] [Abstract][Full Text] [Related]
2. Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis.
Gengenbacher M; Nieuwenhuizen N; Vogelzang A; Liu H; Kaiser P; Schuerer S; Lazar D; Wagner I; Mollenkopf HJ; Kaufmann SH
mBio; 2016 May; 7(3):. PubMed ID: 27222470
[TBL] [Abstract][Full Text] [Related]
3. The tuberculosis vaccine candidate Bacillus Calmette-Guérin ΔureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in mice.
Rao M; Vogelzang A; Kaiser P; Schuerer S; Kaufmann SH; Gengenbacher M
PLoS One; 2013; 8(11):e78966. PubMed ID: 24236077
[TBL] [Abstract][Full Text] [Related]
4. Post-exposure vaccination with the vaccine candidate Bacillus Calmette-Guérin ΔureC::hly induces superior protection in a mouse model of subclinical tuberculosis.
Gengenbacher M; Kaiser P; Schuerer S; Lazar D; Kaufmann SH
Microbes Infect; 2016 May; 18(5):364-8. PubMed ID: 26994939
[TBL] [Abstract][Full Text] [Related]
5. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin.
Grode L; Seiler P; Baumann S; Hess J; Brinkmann V; Nasser Eddine A; Mann P; Goosmann C; Bandermann S; Smith D; Bancroft GJ; Reyrat JM; van Soolingen D; Raupach B; Kaufmann SH
J Clin Invest; 2005 Sep; 115(9):2472-9. PubMed ID: 16110326
[TBL] [Abstract][Full Text] [Related]
6. Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guérin ΔureC::hly vaccine's superior protection against tuberculosis.
Vogelzang A; Perdomo C; Zedler U; Kuhlmann S; Hurwitz R; Gengenbacher M; Kaufmann SH
J Infect Dis; 2014 Dec; 210(12):1928-37. PubMed ID: 24943726
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis.
Tchilian EZ; Desel C; Forbes EK; Bandermann S; Sander CR; Hill AV; McShane H; Kaufmann SH
Infect Immun; 2009 Feb; 77(2):622-31. PubMed ID: 19064635
[TBL] [Abstract][Full Text] [Related]
8. Recombinant BCG ΔureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses.
Desel C; Dorhoi A; Bandermann S; Grode L; Eisele B; Kaufmann SH
J Infect Dis; 2011 Nov; 204(10):1573-84. PubMed ID: 21933877
[TBL] [Abstract][Full Text] [Related]
9. BCG - old workhorse, new skills.
Gengenbacher M; Nieuwenhuizen NE; Kaufmann S
Curr Opin Immunol; 2017 Aug; 47():8-16. PubMed ID: 28719821
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
11. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
[TBL] [Abstract][Full Text] [Related]
12. Heterologous Boost Following
Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
Front Immunol; 2018; 9():2439. PubMed ID: 30425711
[TBL] [Abstract][Full Text] [Related]
13. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
[TBL] [Abstract][Full Text] [Related]
14. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
Lu M; Xia ZY; Bao L
Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
[TBL] [Abstract][Full Text] [Related]
16. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
17. Improved protection against disseminated tuberculosis by Mycobacterium bovis bacillus Calmette-Guerin secreting murine GM-CSF is associated with expansion and activation of APCs.
Ryan AA; Wozniak TM; Shklovskaya E; O'Donnell MA; Fazekas de St Groth B; Britton WJ; Triccas JA
J Immunol; 2007 Dec; 179(12):8418-24. PubMed ID: 18056388
[TBL] [Abstract][Full Text] [Related]
18. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
[TBL] [Abstract][Full Text] [Related]
19.
Jia Q; Masleša-Galić S; Nava S; Horwitz MA
mBio; 2022 Jun; 13(3):e0068722. PubMed ID: 35642945
[TBL] [Abstract][Full Text] [Related]
20. Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.
Xu Y; Yang E; Wang J; Li R; Li G; Liu G; Song N; Huang Q; Kong C; Wang H
Immunology; 2014 Oct; 143(2):277-86. PubMed ID: 24773322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]